AzTrials
AzTrials

GeriatricsNCT04223921

Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier

An observational study of Geriatrics and Clinical Pharmacy, run by University Hospital, Montpellier at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study involves patients who will be discharged from Montpellier University Hospital (acute geriatric care unit) between January and March 2020. The primary objective is to assess the number of difference(s) in patient's medicines between the discharge from hospital (acute geriatric care unit) and one month after… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Geriatrics, Clinical Pharmacy
What is being tested?
Comparison of patient's medicines
How many people
500 participants
Where
1 siteFrance
Study dates
20 Jan 2020to 30 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients who will be discharged from hospital (acute geriatric care unit) between January and March 2020

Who may be able to join

  • patients who will be discharged from hospital (acute geriatric care unit) between January and March 2020 and who will return to their home or to institution for elderly persons
  • patients for whom there will be at least one change in their medicines between their admission and their discharge from hospital

Who cannot join

  • Patients who don't want to participate in this study

Trial locations and contacts

1 site in 1 country.

France1 site
  • UH Montpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier: Follow-up One Month After Discharge From Hospital

This study involves patients who will be discharged from Montpellier University Hospital (acute geriatric care unit) between January and March 2020.

The primary objective is to assess the number of difference(s) in patient's medicines between the discharge from hospital (acute geriatric care unit) and one month after this discharge.

Read more

The secondary objectives are:

  • to assess the number of changes of medicines between the patient's admission and discharge from hospital (acute geriatric care unit);
  • to evaluate the number of inappropriate medicines in patient's treatment at hospital admission (in acute geriatric care unit) and one month after the discharge from hospital;
  • to evaluate the number of failures found in the transmission of information between the hospital and the general practitioner/pharmacy one month after the patient's discharge from hospital (acute geriatric care unit).
Being tested
Comparison of patient's medicines
Keywords
Medication reconciliation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comparison of patient's medicinesOther

    Comparison of patient's medicines:

    • between patient's discharge from hospital and one month after this discharge (acute geriatric care unit)
    • between patient's admission and discharge from hospital (acute geriatric care unit
Study groups in NCT04223921
Study groupRoleWhat they receive
Patients who will be discharged from hospital (acute geriatricPatients who will be discharged from hospital (acute geriatric care unit) between January and March 2020
Receives: Other: Comparison of patient's medicines

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of medicines prescribed

    Number of medicines prescribed by general practitioner different from those prescribed at patient's discharge from hospital (acute geriatric care unit)

    Measured: One month after discharge from hospital (acute geriatric care unit)

Secondary outcomes (1)
  1. Number of medicines' changes

    Number of changes of medicines between the patient's admission and discharge from hospital (acute geriatric care unit)

    Measured: At patient's discharge from hospital (acute geriatric care unit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2020
  2. Study start20 Jan 2020
  3. Primary completion1 Mar 2020
  4. Study completion30 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04223921
Sponsor's protocol ID
RECHMPL19_0581
Status last verified
Jun 2020
First submitted
2 Jan 2020
Last updated
5 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Geriatrics and Clinical Pharmacy, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of medicines prescribed (time frame: One month after discharge from hospital (acute geriatric care unit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in